These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 1160831)
1. [Values of calcium electrolytes in patients treated with cardiac glycosides]. Surbat L Med Pregl; 1975; 28(5-6):217-9. PubMed ID: 1160831 [No Abstract] [Full Text] [Related]
2. [Cardiac glycosides]. Pankratov AB Med Sestra; 1978 Mar; 37(3):34-40. PubMed ID: 247167 [No Abstract] [Full Text] [Related]
3. [Erychroside treatment of patients with circulatory insufficiency]. Belostochnaia NG Vrach Delo; 1966 Dec; 12():30-4. PubMed ID: 6002712 [No Abstract] [Full Text] [Related]
4. [Treatment of cardiac insufficiency with a new cardiac glycoside--cuspidoside]. Iuldashev UI; Ibragimova MSh; Babadzhanova EG; Mavlanov FM Ter Arkh; 1978; 50(1):69-70. PubMed ID: 635802 [No Abstract] [Full Text] [Related]
5. [Progress in the internistic treatment of heart diseases]. Aschenbrenner R Anglo Ger Med Rev; 1967 Dec; 4(1):200-8. PubMed ID: 5590772 [No Abstract] [Full Text] [Related]
6. [Clinical tests of a new cardiac glycoside]. Wiontzek H; Eilmes G; Gaedt R; Haack U Ther Ggw; 1972 Jan; 111(1):46-51. PubMed ID: 4554143 [No Abstract] [Full Text] [Related]
7. [Clinical experience with a new cardiac glycoside]. Büsscher K Z Allgemeinmed; 1969 Feb; 45(6):265-8. PubMed ID: 5801646 [No Abstract] [Full Text] [Related]
8. [Experience in the use of cardiac glycosides in children with heart diseases]. Landa NM; Shcherbatova EI Vopr Okhr Materin Det; 1971 Jun; 16(6):69-73. PubMed ID: 5112039 [No Abstract] [Full Text] [Related]
9. [Therapeutic note on the use of talusin and theo-talusin in ambulatory patients]. Wirthner H Praxis; 1969 Oct; 58(42):1350-1. PubMed ID: 5396158 [No Abstract] [Full Text] [Related]
10. [The significance of phase analysis in the pharmacotherapeutic control of the effect of cardiac glycosides]. Belostochnaia NG Ter Arkh; 1967 Apr; 39(4):65-7. PubMed ID: 5610908 [No Abstract] [Full Text] [Related]
11. [Are cardiac glycosides recommended following an attack of encephalomalacia?]. Aschenbrenner R Dtsch Med Wochenschr; 1968 Jan; 93(1):48. PubMed ID: 5635032 [No Abstract] [Full Text] [Related]
12. [Proscillaridin A in some senile heart diseases. Preliminary clinico-therapeutic observations]. Guerricchio G; Basile F; Tantalo L Minerva Med; 1966 May; 57(43 Suppl):1982-90. PubMed ID: 5943256 [No Abstract] [Full Text] [Related]
13. [Structure and effect of cardiac glycosides from the clinical viewpoint]. Sundermann A; Fiehring H Dtsch Gesundheitsw; 1967 May; 22(20):919-23. PubMed ID: 5600800 [No Abstract] [Full Text] [Related]
14. [Data on the hospital treatment of heart disease patients with proscillaridin A]. Saccabusi E Recenti Prog Med; 1966 Jul; 41(1):XLIII-LIV. PubMed ID: 6014476 [No Abstract] [Full Text] [Related]
15. [Rational use of cardiac glycosides in certain diseases in childhood]. Sidel'nikov VM; Afanas'ev EN; Liutkevich VF Pediatr Akus Ginekol; 1975; (3):3-6. PubMed ID: 1230764 [No Abstract] [Full Text] [Related]
16. [Action of oral proscillaridin treatment in various forms of heart insufficiency]. Muth HW; Weyer H Med Welt; 1965 Dec; 51():2883-6. PubMed ID: 5884860 [No Abstract] [Full Text] [Related]
17. [Treatment of heart failure with gomphotin]. Angarskaia MA; Bezruk PI; Krivolutskaia OI Sov Med; 1966 Nov; 29(11):28-31. PubMed ID: 6004472 [No Abstract] [Full Text] [Related]